Ambrx Biopharma Inc. (AMAM) Financials
Stock symbol AMAM is outdated, potentially delisted? Maybe it is available on other exchange?
AMAM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 271.5 million | 29.1 million |
| June 30, 2023 | 279.9 million | 29.6 million |
| March 31, 2023 | 210.6 million | 28.0 million |
| Dec. 31, 2022 | 147.0 million | 29.1 million |
AMAM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -19.2 million | 4.8 million |
| June 30, 2023 | -13.9 million | 2.9 million |
| March 31, 2023 | -13.0 million | 1.9 million |
| Dec. 31, 2022 | -12.8 million | 1.2 million |
AMAM Net Income
No data available :(
AMAM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 225.3 million | - | 10.5 million |
| June 30, 2023 | 235.1 million | - | 11.0 million |
| March 31, 2023 | 157.5 million | - | 11.5 million |
| Dec. 31, 2022 | 84.5 million | - | 12.0 million |
AMAM Shares Outstanding
AMAM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 298000 | 16.3 million | 9.4 million | - |
| June 30, 2023 | 783000 | 14.4 million | 5.9 million | - |
| March 31, 2023 | 783000 | 9.8 million | 6.1 million | 1.3 million |
| Dec. 31, 2022 | 47000 | 10.3 million | 5.6 million | 681500 |
AMAM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 53000 | - |
| June 30, 2023 | 1.1 million | - |
| March 31, 2023 | 24000 | - |
| Dec. 31, 2022 | 2.2 million | - |
AMAM
Price: $28
52 week price:
Earnings Per Share: 0.42 USD
P/E Ratio: 66.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 261163
Market Capitalization: 1.8 billion